FePt nanoparticles: a novel nanoprobe for enhanced HeLa cells sensitivity to chemoradiotherapy
- 4 April 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 6 (41), 35124-35134
- https://doi.org/10.1039/C6RA03990A
Abstract
The present work exhibited high therapeutic efficacy of FePt nanoparticles in combination with radiotherapy without apparent cytotoxicity, suggesting the potential of FePt nanoparticles as a promising nanoprobe in improving the outcome of tumor chemoradiotherapy.Keywords
This publication has 45 references indexed in Scilit:
- Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen depositionBMC Cancer, 2014
- Early Complications of High-dose-rate Brachytherapy in Soft Tissue Sarcoma: A Comparison With Traditional External-beam RadiotherapyClinical Orthopaedics and Related Research, 2012
- Comparison of Dose Response Models for Predicting Normal Tissue Complications from Cancer Radiotherapy: Application in Rat Spinal CordCancers, 2011
- Cell-Specific Radiosensitization by Gold Nanoparticles at Megavoltage Radiation EnergiesInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Engineered Biocompatible Nanoparticles for in Vivo Imaging ApplicationsJournal of the American Chemical Society, 2010
- Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic NanoparticlesAdvanced Materials, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Chemoradiotherapy for head and neck cancer: current status and perspectivesInternational Journal of Clinical Oncology, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002